BCL6-Mediated Escape from Negative Selection Enables RAS-Driven B-Cell Transformation

被引:0
|
作者
Chan, Lai N. [1 ,2 ]
Hurtz, Christian [3 ]
Robinson, Mark E. [1 ,2 ]
Leveille, Etienne [1 ,2 ]
Geng, Huimin [4 ]
Caeser, Rebecca [5 ]
Xu, Liang [6 ]
Kume, Kohei [7 ,8 ]
Xiao, Gang [6 ]
Muschen, Markus [1 ,2 ]
机构
[1] Yale Univ, Ctr Mol & Cellular Oncol, New Haven, CT USA
[2] Yale Univ, Dept Immunobiol, New Haven, CT USA
[3] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA
[4] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[6] Zhejiang Univ, Coll Life Sci, Hangzhou, Peoples R China
[7] Yale Univ, Ctr Mol & Cellular Oncol, Duarte, CA USA
[8] Yale Univ, Dept Immunobiol, Duarte, CA USA
关键词
D O I
10.1182/blood-2022-169946
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:9177 / 9178
页数:2
相关论文
共 50 条
  • [21] Predictive value of Bcl-2 and Bcl-6 protein expression in diffuse large B-cell lymphoma patients from a single institution.
    Paszkiewicz-Kozik, E
    Mioduszewska, O
    Federowicz, I
    Kraszewska, E
    Kulczycka, E
    Domanska-Czyz, K
    Ostrowska, B
    Romejko-Jarosinska, J
    Osowiecki, M
    Walewski, JA
    BLOOD, 2004, 104 (11) : 220B - 220B
  • [22] DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations
    Akpa, Chidimma Agatha
    Kleo, Karsten
    Lenze, Dido
    Oker, Elisabeth
    Dimitrova, Lora
    Hummel, Michael
    PLOS ONE, 2019, 14 (08):
  • [23] A critical BCL6-related feedback loop explains the unusual biological features of germinal center B-cells and their malignant transformation into B-cell lymphomas.
    Ranuncolo, Stella M.
    Polo, Jose M.
    Dierov, Jamil
    Carroll, Martin
    Melnick, Ari M.
    BLOOD, 2006, 108 (11) : 70A - 70A
  • [24] Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells
    María G. Cortiguera
    Lorena García-Gaipo
    Simon D. Wagner
    Javier León
    Ana Batlle-López
    M. Dolores Delgado
    Scientific Reports, 9
  • [25] Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells
    Cortiguera, Maria G.
    Garcia-Gaipo, Lorena
    Wagner, Simon D.
    Leon, Javier
    Batlle-Lopez, Ana
    Dolores Delgado, M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [26] AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation
    Yang, Ming
    Long, Di
    Hu, Longyuan
    Zhao, Zhidan
    Li, Qianwen
    Guo, Yunkai
    He, Zhenghao
    Zhao, Ming
    Lu, Liwei
    Li, Fen
    Long, Hai
    Wu, Haijing
    Lu, Qianjin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [27] LYMPHOMA MODELS FOR B-CELL ACTIVATION AND TOLERANCE .6. REVERSAL OF ANTI-IG-MEDIATED NEGATIVE SIGNALING BY T-CELL-DERIVED LYMPHOKINES
    SCOTT, DW
    OGARRA, A
    WARREN, D
    KLAUS, GGB
    JOURNAL OF IMMUNOLOGY, 1987, 139 (12): : 3924 - 3929
  • [28] Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma - Evidence for derivation from germinal center B cells?
    de Leval, L
    Ferry, JA
    Falini, B
    Shipp, M
    Harris, NL
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (10) : 1277 - 1282
  • [29] High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry
    Leskova, Katarina
    Szepe, Peter
    Balharek, Tomas
    Barthova, Martina
    Janakova, Luboslava
    Farkasova, Anna
    Plank, Lukas
    NEOPLASMA, 2022, 69 (04) : 957 - 964
  • [30] AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1–Bcl-6 axis-mediated B-cell differentiation
    Ming Yang
    Di Long
    Longyuan Hu
    Zhidan Zhao
    Qianwen Li
    Yunkai Guo
    Zhenghao He
    Ming Zhao
    Liwei Lu
    Fen Li
    Hai Long
    Haijing Wu
    Qianjin Lu
    Signal Transduction and Targeted Therapy, 6